BridgeMD
New treatment option for Parkinson Disease
Official title Microbiome and Diet in Parkinson's Disease
ClinicalTrials.gov ID: NCT06207136
What this study is testing
- What it's testing
- The goal of this pilot study is to examine the feasibility and effects of an 18-month intervention diet compared to an active control diet (standard diet) in those living with Parkinson's Disease (PD), without dementia. Research has shown that eating components of Mediterranean diets are associated with a 30% lower risk to develop PD and a 40% lower mortality rate in those living with PD.
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 40 to 80
You may be able to join if
- Eligible if the person living with Parkinson's has/is:
- a clinical diagnosis of PD,
- cognitively stable (no clinical dementia),
- between 40-80 years old,
- able to travel to UBC for 6 onsite visits over 18 months,
You likely can't join if
- Not eligible, if person has/is:
- a diagnosis of atypical parkinsonism,
- medical or psychiatric conditions that would prevent full participation in the nutrition intervention (such as food allergies), significant...
- clinical dementia,
- unable to complete questionnaires or understand study instructions,
- using of immunomodulatory agents,
See the full eligibility criteria
- Eligible if the person living with Parkinson's has/is:
- a clinical diagnosis of PD,
- cognitively stable (no clinical dementia),
- between 40-80 years old,
- able to travel to UBC for 6 onsite visits over 18 months,
- sufficient English proficiency (coaching and cooking classes are in English only),
- on a stable dopaminergic medication for at least one month before baseline,
- computer and internet access at home, and can be available via video link for at least 80% of the study sessions.
- Not eligible, if person has/is:
- a diagnosis of atypical parkinsonism,
- medical or psychiatric conditions that would prevent full participation in the nutrition intervention (such as food allergies), significant dysphagia, diabetes on insulin, anti-coagulation on warfarin, and inflammatory...
- clinical dementia,
- unable to complete questionnaires or understand study instructions,
- using of immunomodulatory agents,
- used Probiotics in the last 4 weeks prior to study start,
- used Antibiotics in the last 3 months prior to study start,
- contraindications for MRI.
The study team makes the final eligibility decision.
Where it's taking place
- Vancouver, British Columbia, Canada
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 40 years to 80 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Vancouver, British Columbia, Canada. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.